Czernin, Klara
Bründlmayer, Anselm
Oster, Anna
Baumgartner, Josef S.
Plener, Paul L.
Funding for this research was provided by:
Universitätsklinikum Ulm
Article History
Received: 19 March 2024
Accepted: 26 July 2024
First Online: 13 August 2024
Declarations
:
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2000. The study was approved by the Ethics Committee of the Medical University of Vienna (reference no.: 1639/2019).
: Not applicable.
: KC, AB, AO, and JSB report no competing interests. PLP received research funding from the German Federal Ministry of Education and Research (BMBF), the German Federal Institute for Drugs and Medical Devices (BfArM), the Volkswagen Foundation, the Baden-Wuerttemberg Foundation, the Viennese Landeszielsteuerungskommission, the Erste Bank Foundation, the Hochschuljubiläumsfonds, the Zukunftsfonds, Servier and Lundbeck. He acts as an advisor for Boehringer-Ingelheim and receives royalties from Hogrefe publishers and has received speaker´s honoraria from GSK, Consilium, Janssen and Oral B.